Found: 25
Select item for more details and to access through your institution.
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17271-3
- By:
- Publication type:
- Article
Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 9, p. 1841, doi. 10.3390/life13091841
- By:
- Publication type:
- Article
Low‐risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 776, doi. 10.1111/bjh.18912
- By:
- Publication type:
- Article
Real‐world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR‐2 retrospective chart review study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 749, doi. 10.1111/bjh.18519
- By:
- Publication type:
- Article
Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 3, p. 306, doi. 10.1111/bjh.18522
- By:
- Publication type:
- Article
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 480, doi. 10.1111/bjh.15805
- By:
- Publication type:
- Article
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 699, doi. 10.1111/bjh.14831
- By:
- Publication type:
- Article
Fatal graft-versus-host disease after allogeneic stem cell transplantation in a patient recently exposed to nivolumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 2, p. 502, doi. 10.1177/1078155217743069
- By:
- Publication type:
- Article
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1285, doi. 10.3390/cancers16071285
- By:
- Publication type:
- Article
Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4022, doi. 10.3390/cancers15164022
- By:
- Publication type:
- Article
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 21, p. 7629, doi. 10.1002/cam4.4293
- By:
- Publication type:
- Article
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 2766, doi. 10.1002/cam4.1217
- By:
- Publication type:
- Article
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1188818
- By:
- Publication type:
- Article
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1188818
- By:
- Publication type:
- Article
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1188818
- By:
- Publication type:
- Article
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211039326
- By:
- Publication type:
- Article
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e844, doi. 10.1016/j.clml.2022.04.024
- By:
- Publication type:
- Article
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00652-2
- By:
- Publication type:
- Article
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 2, p. 305, doi. 10.1111/cts.13450
- By:
- Publication type:
- Article
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP).
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 1, p. 83, doi. 10.1007/s40487-022-00212-5
- By:
- Publication type:
- Article
Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-57570-5
- By:
- Publication type:
- Article